Source: FDA, National Drug Code (US) Revision Year: 2025
BRINSUPRI is indicated for the treatment of non-cystic fibrosis bronchiectasis (NCFB) in adult and pediatric patients 12 years of age and older.
The recommended dosage of BRINSUPRI is as follows:
Patients who miss a dose should take the next dose at their regular time the next day. Do not double the dose to make up for the missed dose.
Consider contacting the Poison Help line (1-800-222-1222) or a medical toxicologist for overdose management recommendations.
Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Store in original container.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.